Southern RNA

We are a Australian contract development and manufacturing organisation (CDMO) specialising in the production of nucleic acid products (mRNA) that support life-enabling work. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. Developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing approaches, employing a highly-skilled Australian workforce

Messenger rna,lipid nanoparticles,plasmiddna,mrna,vaccines,covid-19 vaccine,cancer,nucleic acid, sequence design,next-generation sequencing,ivt,linear plasmid dna,co cap a,co transcriptional capping,bio processing,supercoiled plasmid dna ,method development,vaccine design,quality control and analytical testing ,and co cap™ a

Southern rna operates in the Biotechnology research industry.

Southern rna's revenue is 11m - 100m

Southern rna has 11 - 50 employees.